Abstract
Medium spiny neurons (MSNs), the major GABAergic projection neurons in the striatum, are implicated in many neuropsychiatric diseases such as schizophrenia, but the underlying mechanisms remain unclear. We found that a deficiency in Erbb4, a schizophrenia risk gene, in MSNs of the nucleus accumbens (NAc) core, but not the dorsomedial striatum, markedly induced schizophrenia-like behaviors such as hyperactivity, abnormal marble-burying behavior, damaged social novelty recognition, and impaired sensorimotor gating function in male mice. Using immunohistochemistry, Western blot, RNA interference, electrophysiology, and behavior test studies, we found that these phenomena were mediated by increased GABAA receptor α1 subunit (GABAAR α1) expression, which enhanced inhibitory synaptic transmission on MSNs. These results suggest that Erbb4 in MSNs of the NAc core may contribute to the pathogenesis of schizophrenia by regulating GABAergic transmission and raise the possibility that GABAAR α1 may therefore serve as a new therapeutic target for schizophrenia.
SIGNIFICANCE STATEMENT Although ErbB4 is highly expressed in striatal medium spiny neurons (MSNs), its role in this type of neuron has not been reported previously. The present study demonstrates that Erbb4 deletion in nucleus accumbens (NAc) core MSNs can induce schizophrenia-like behaviors via elevated GABAA receptor α1 subunit (GABAAR α1) expression. To our knowledge, this is the first evidence that ErbB4 signaling in the MSNs is involved in the pathology of schizophrenia. Furthermore, restoration of GABAAR α1 in the NAc core, but not the dorsal medium striatum, alleviated the abnormal behaviors. Here, we highlight the role of the NAc core in the pathogenesis of schizophrenia and suggest that GABAAR α1 may be a potential pharmacological target for its treatment.
Introduction
The striatum, the largest nucleus of the basal ganglia in the forebrain, is well known for its regulation of voluntary movement and cognition and nearly 95% of striatal neurons are GABAergic medium spiny neurons (MSNs) (Kreitzer, 2009; Crittenden and Graybiel, 2011). The striatum consists of the nucleus accumbens (NAc) in the ventral area and the caudate putamen (CPu) in the dorsal area. The NAc, which consists of the core and the shell, is a classical regulator of reward-related behaviors (Russo and Nestler, 2013). In addition, a recent review described the NAc as an interface among cognition, emotion, and action (Floresco, 2015). In contrast, the CPu, which is composed of the dorsolateral striatum (DLS) and dorsomedial striatum (DMS), is mainly involved in motivation, decision making, goal direction, and habituation behaviors (Haber, 2003; Balleine et al., 2007; Jahanshahi et al., 2015). MSN dysfunction in either the NAc or the CPu has been implicated in the pathogenesis of neuropsychiatric diseases such as schizophrenia, obsessive-compulsive disorder, and Parkinson's disease (Mehler-Wex et al., 2006; Rauch et al., 2006; Simpson et al., 2010; Okada et al., 2016). However, the mechanisms underlying how MSN dysfunction is involved in neuropsychiatric diseases including schizophrenia remain unclear.
Erbb4 is a susceptibility gene of schizophrenia (Mei and Xiong, 2008). Various Erbb4 SNPs associated with schizophrenia have been revealed by genome-wide studies (Nicodemus et al., 2006; Silberberg et al., 2006; Shi et al., 2009; Lu et al., 2010; Agim et al., 2013) and Erbb4 microdeletions or microduplications were detected in patients with schizophrenia (Walsh et al., 2008). In addition to human genetic studies, evidence from Erbb4-mutant mice further validated the possible causal effect of ErbB4 malfunction to schizophrenia. Erbb4 mutant mice showed “schizophrenia-like” behavioral deficits, in contrast to the overtly normal performance by Erbb2- and Erbb3-heterozygous/null mice (Gerlai et al., 2000; Golub et al., 2004). Among the various brain regions and neuronal types where Erbb4 is expressed, ErbB4 function in the cortical and hippocampal neurons has been studied intensely (Hahn et al., 2006; Pitcher et al., 2011; Del Pino et al., 2013; Mitchell et al., 2013; Seshadri et al., 2015; Zhou et al., 2015b), but relatively little is known about its role in other brain areas. We found surprisingly high ErbB4 expression in MSNs in the striatum and investigated its potential roles in the striatal neurons in the regulation of animal behaviors.
In the current study, we deleted Erbb4 specifically in MSNs of the NAc core and observed schizophrenia-like behaviors. Furthermore, by combining Western blotting, electrophysiology, RNA interference, and immunohistochemistry, we found that GABAA receptor α1 subunit (GABAAR α1) expression was elevated in MSNs of the NAc core, which accounts for the behavioral phenotypes induced by ErbB4 deficiency. These results indicate that ErbB4 in MSNs of the NAc core plays an important role in mediating the pathogenesis of schizophrenia.
Materials and Methods
Mice.
The Dlx5/6-Cre;Erbb4loxp/loxp line was generated by crossing Dlx5/6-Cre mice (The Jackson Laboratory; Zerucha et al., 2000) with Erbb4loxp/loxp mice (Mutant Mouse Regional Resource Center). The Dlx5/6-Cre;Ai9 line was obtained by crossing Dlx5/6-Cre mice with Ai9 mice (The Jackson Laboratory; Vullhorst et al., 2009) that express tdTomato under the control of a Cre-dependent promoter. For ErbB4 detection in cKO mice, we crossed Dlx5/6-Cre;Erbb4loxp/loxp mice with Ai9 mice to label the MSNs with tdTomato. Dlx5/6-flp;Erbb4loxp/loxp mice were acquired by crossing Dlx5/6-flp mice (kindly provided by Z. Josh Huang, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, and Dr. Miao He, Institutes of Brain Science, Fudan University, Shanghai, China) with Erbb4loxp/loxp mice. Dlx5/6-flp;Ai65 mice were obtained by crossing Dlx5/6-flp mice with Ai65 mice (The Jackson Laboratory; Madisen et al., 2015). Cells in Ai65 mice show red fluorescence only when Cre and Flp recombinases are present simultaneously. Mice were housed under a 12 h light/dark cycle and had access to food and water ad libitum. All mouse lines were crossed with the C57BL/6J background for >10 generations. Only male mice 8–13 weeks of age were used for all behavioral tests, immunohistochemistry, Western blot, and electrophysiology studies. All animal use procedures were reviewed and approved by the Animal Advisory Committee at Zhejiang University and the National Institutes of Health's Guidelines for the Care and Use of Laboratory Animals.
Tissue sample preparation.
Protein samples were prepared from 8- to 13-week-old male mice. Mice were decapitated rapidly and the brains were quickly removed on ice. Two knife blades were tightened together with 1 mm interstice to insure the tissue thickness limited to 1 mm. After removing the olfactory bulb, the second 1 mm coronal section was selected to dissect the NAc core part and the second and third 1 mm sections were used for the DMS separation. Surrounding anterior commissure 0.5 mm was selected as the NAc core tissue. After disassociating the dorsal striatum by cutting along the corpus callosum and lateral ventricle, the medial 1 mm part was selected as the DMS tissue. All corresponding brain regions were dissected bilaterally on an ice-cooled plate. Dissected brain tissues were then transferred to a −80°C freezer. Separated tissues were homogenized with an electrical disperser (Wiggenhauser) after 30 min in RIPA lysis buffer with protease and phosphatase inhibitors (Beyotime Biotechnology) containing the following: 20 mm Tris, pH 7.5, 150 mm NaCl, 1% Triton X-100, 2.5 mm sodium pyrophosphate, 1 mm EDTA, 1% Na3VO4, 0.5 μg/ml leupeptin, and 1 mm phenylmethanesulfonyl fluoride. The tissue homogenates were then centrifuged at 12,000 × g for 10 min at 4°C. All protein sample concentrations were determined with the bicinchoinic acid assay (Beyotime Biotechnology).
Western blot assays.
Western blot assay procedures were based on those used in our previous studies (Li et al., 2011; Yang et al., 2013). Loading buffer (5×; Beyotime Biotechnology) was added to each sample (4:1 sample:loading buffer) before boiling for 5 min. Protein samples were run on 10% SDS-polyacrylamide gels and then transferred to polyvinylidene difluoride membranes. After blocking in 3% nonfat milk for 1 h at room temperature (RT), membranes were incubated with the respective primary antibodies at 4°C overnight (rabbit anti-ErbB4, 1:2000, ab32375, Abcam, RRID: AB_731579; rabbit anti-GABAAR α1, 1:1000, 06-868, Millipore, RRID: AB_310272; rabbit anti-GABAAR α2, 1:1000, ab72445, Abcam, RRID: AB_1268929; rabbit anti-GABAAR β2, 1:1000, ab8340, Abcam, RRID: AB_306495; goat anti-gephyrin, 1:500, sc-6411, Santa Cruz Biotechnology, RRID: AB_640962; rabbit anti-GAPDH, 1:5000, 5174, Cell Signaling Technology, RRID: AB_10622025; Mouse anti GluN1, 1:500, 05-432, Millipore, RRID: AB_10015247; rabbit anti GluN2A, 1:500, 07-632, Millipore, RRID: AB_11213002; rabbit anti GluN2B, 1:1000, 06-600, Millipore, RRID: AB_310193). After washing 3 times in 0.1% Tween 20 in TBS, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies in 3% nonfat milk for 1 h at RT and visualized with an ECL kit (Thermo Scientific). Quantitative analysis was performed with ImageJ software. Each experiment was performed at least three times. The data for statistical analyses were from at least three mice per group.
Immunohistochemistry.
Immunohistochemistry was performed on 40-μm-thick sections as described previously (Yang et al., 2013). After deep anesthesia, the relevant male mice were perfused with ice-cold saline followed by 4% paraformaldehyde (Christoffel et al., 2015) in 0.1 m PBS, pH 7.4. The brains were removed, postfixed overnight in 4% PFA at 4°C, and transferred to 30% sucrose in 0.1 m PBS, pH 7.4. Coronal sections (40 μm) were cut on a cryostat (Leica CM3050 S) and stored in 0.1 m PBS. The sections were incubated in blocking buffer containing 3% bovine serum albumin and 5% normal goat serum in 0.2% Triton X-100/PBS (PBST) for 1 h at RT and then with primary antibodies in blocking buffer overnight at 4°C (mouse anti-ErbB4, 1:500, a kind gift from Cary Lai; rabbit anti-DARPP32, 1:2000, 2306S, Cell Signaling Technology, RRID: AB_823479; mouse anti-parvalbumin (PV), 1:5000, 235, Swant, RRID: AB_10000343; rabbit anti-choline acetyltransferase (ChAT, a cholinergic neuronal marker), 1:400, 297 013, Synaptic Systems, RRID: AB_2620040). After three washes with PBST, sections were incubated with Alexa Fluor 488- or Alexa Fluor 543-conjugated secondary antibodies at RT for 1 h. After another three washes in PBST, sections were mounted with Prolong anti-fade medium (Invitrogen).
Perisomatic GABAA receptor α1 subunit analysis.
Sections were processed identically and immunohistochemical experiments were repeated at least three times to ensure reliability. Images of the NAc core were captured from a single confocal plane with 60× oil-immersion objective lens (numerical aperture 1.4) on an inverted confocal microscope (Nikon A1R). All images were acquired using the same parameters. Gray levels of perisomatic GABAAR α1 (<2 μm away from the soma membrane) were measured using ImageJ software and the nucleus of each neuron was selected as the background reference region. Image capture and analysis were performed by investigators who were blind to the genotype and virus injection.
Electrophysiology analysis.
Male mice (8–13 weeks old) were deeply anesthetized and decapitated. The brain was quickly removed and placed in ice-cold artificial CSF (ACSF) containing the following (in mm): 125 NaCl, 2.5 KCl, 11 d-glucose, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, and 2 MgCl2. The solution was bubbled with 95% O2/5% CO2 to maintain a pH of ∼7.4. Coronal slices (300 μm) containing striatum were cut on a microtome (Leica VT1200S). The slices were stored for 30–45 min at 37°C in oxygenated ACSF and then kept at RT.
Electrophysiology assay procedures were based on those used in our previous studies (Li et al., 2011; Yang et al., 2014). Individual slices were transferred to a recording chamber and fully submerged in continuously perfused (2–3 ml/min) oxygenated ACSF maintained at 34 ± 2°C. Recording neurons were all MSNs in the CPu or NAc identified by tdTomato-positive or virus transfected GFP-positive cells. To record miniature IPSCs (mIPSCs), we used pipette solution containing the following (in mm): 130 CsCl, 4 NaCl, 10 TEA, 10 HEPES, 2 Na2-ATP, 0.5 Na3-GTP, and 0.2 EGTA; pH was adjusted to 7.25 with 10 m CsOH; tetrodotoxin (1 μm; to block sodium current), DL-2-amino-5-phosphonopentanoic acid (50 μm, Tocris Bioscience; to block NMDA receptors), and 6, 7-dinitroquinoxaline-2, 3(1H, 4H)-dione (20 μm, Tocris Bioscience; to block AMPA receptors) were present in the bath solution and neurons were voltage clamped at −70 mV. To record mEPSCs, we used pipette solution containing the following (in mm): 130 CsMeSO3, 4 NaCl, 10 TEA, 10 HEPES, 2 Na2-ATP, 0.5 Na3-GTP, and 0.2 EGTA; pH was adjusted to 7.25 with 10 m CsOH; tetrodotoxin (1 μm; to block sodium current); picrotoxin (100 μm; to block GABAA receptors) were present in the bath solution and neurons were voltage clamped at −70 mV. Recordings were started 2–3 min after a stable whole-cell configuration was obtained. Access resistance (<20 MΩ) was not compensated and was monitored continually throughout each experiment. Recordings were terminated whenever input resistance increased >30% or access resistance exceeded 20 MΩ. mIPSCs under these conditions are inward. Signals were acquired using an Molecular Devices MultiClamp 700B amplifier controlled by Clampex 10.2 software via a Digidata 1440A interface (Molecular Devices). Responses were filtered at 2 kHz, digitized at 10 kHz, and analyzed using Clampfit 10.2 (Molecular Devices) and Mini Analysis 6.0 software (Synaptosoft). The root-mean-square noise level was 2–4 pA and a threshold of 12 pA was used to detect and measure mIPSCs. Whole-cell recordings were acquired from the CPu and the NAc core. Collected events were averaged for amplitude and frequency measurements.
Behavior.
For all behavior tests, only 8- to 13-week-old male mice were used and the number of mice for each behavior test is presented in the corresponding figure legend. The experimenter was blind to genotype while conducting and analyzing the experiments.
For the open-field test, the size of the open-field box was 45 × 45 × 45 cm. Mice were introduced into the center of the chamber at the beginning of the test and movements were recorded with a video camera for 15 min. Speed <2 cm/s was defined as immobility. Locomotor activity was evaluated as the distance traveled per 5 min and the total distance.
For the marble bury test, similar to a previous study (Deacon, 2006), large empty cages (40 × 24 × 20 cm) for the marble-burying test were filled with bedding up to 4 cm from the cage floor and 20 blue marbles were positioned in 4 × 5 grid pattern throughout the cage. Mice were allowed to explore the cage freely for 30 min and then the number of successfully buried marbles was counted. A marble was defined as buried when <25% of it was visible. The experiment was recorded with a digital video camera.
The three-chamber test comprised three phases. In the first phase, a mouse was placed in the three-chambered polycarbonate apparatus and allowed to explore freely for 10 min for habituation. In the second phase, the test mouse was gently placed in the center chamber with both gates to the side chambers closed. A stranger mouse (Stranger 1) was then introduced into one side chamber. Gates were then opened and the test mouse was allowed to explore the new environment freely for 10 min. In the last phase, the test mouse was introduced into the center chamber, again with both gates closed, and another stranger mouse (Stranger 2) was placed in the remaining empty side chamber. The test mouse was allowed to explore the environment freely again for 10 min. Time spent (or distance traveled) within 2 cm of each chamber was recorded for each session of the test. If a mouse showed preference to one side chamber in the first phase, it would be excluded from the test. The preference index was defined as the numerical difference between the time spent exploring the targets (Stranger1 vs Empty or Stranger 2 vs Stranger 1) divided by the total time spent exploring both targets.
For the prepulse inhibition (PPI) test, mice were placed in a clear Plexiglas cylinder in 1 of 2 SR-Lab System startle chambers (San Diego Instruments) for a 5 min acclimation period. A 70 dB broadband background noise was presented during acclimation and throughout the test session. During the test session, mice were presented with startle trials (20 ms 120 dB broadband sound pulse) and prepulse plus startle trials (20 ms noise prepulse sound followed by a 20 ms 120 dB broadband sound pulse with a 100 ms interval). The prepulse plus startle trials were preceded and followed by five pulse-only trials, which were not included in the analyses. Test trials consisted of 10 trials of 3 different intensities (5, 10, and 15 dB above background). Startle trials were performed 5 times and prepulse plus startle trials were performed 10 times with a variable interval of 5–60 s between each presentation. Startle amplitude was measured every 1 ms with a 60 ms period beginning at the onset of the startle stimulus. The peak startle amplitude over the sampling period was taken as the dependent variable. Whole-body startle responses were measured via vibrations transduced into analog signals by a piezoelectric unit attached to the platform on which the cylinders rested. Percentage PPI of startle was calculated as (startle response for startle-alone trials − startle response for prepulse and startle trials)/startle response for startle-alone trials × 100.
Design and cloning of short hairpin RNA constructs.
shRNA specifically targeting the mouse GABAA receptor α1 subunit (GenBank accession NC000077) was designed and cloned. A 19 nt small interfering RNA (siRNA) sequence (5′-CCACTGTCTTCACAAGAAT-3′) was verified with a BLAST search. A nonrelated 19 nt sequence (5′-TTCTCCGAACGTGTCACGT-3′) was used as a scrambled control. The GABAAR α1 shRNA was cloned into the modified pAAV vector pSB0211 pMT3 containing a U6 promoter (Shiao Med Pharma Biotechnology) to drive shRNA expression and EF1α to drive EGFP expression.
Stereotaxic surgery and viral infusion examination.
AAV-shRNA-α1-GFP (and scrambled control virus) and AAV-fDIO-Cre-GFP (and control virus) were produced by Shiao Med Pharma Biotechnology. Two-month-old mice were anesthetized and placed in a stereotaxic system. Viruses were delivered with glass micropipettes. The stereotaxic coordinates were AP + 0.5 mm, ML ± 1.9 mm, and DV + 3.2 mm for the dorsomedial striatum and AP + 1.34 mm, ML ± 0.8 mm, and DV + 4.6 mm for the NAc core. A total of 1 μl of virus was injected bilaterally into the dorsomedial striatum within 20 min and 500 nl of virus was injected into the NAc core within 10 min. After surgery, mice were returned to the home cage and maintained for 3 weeks to ensure virus expression before behavioral tests were performed. To avoid the potential interference from off-target viral expression, brains from animals receiving injection were perfused, sectioned, and checked with a microscope under GFP fluorescence in the targeted region. For the NAc core, virus expression should be limited to the surrounding anterior commissure 0.5 mm area. For the DMS, virus expression should be limited to the medial 1 mm part of the CPu. Those mice with inaccurate viral injection were excluded from all the relevant analysis.
Experimetal design and statistical analysis.
To detect what kind of neurons were labeled in the Dlx5/6-cre-Ai9-tdTomato mice, we used three male mice for immunostaining of different neuron markers such as DARPP32, PV, and ChAT and calculated the percentage of each neuronal type in tdTomato-positive cells. For the ErbB4 deletion experiment, three control (Con) and three conditional knock-out (cKO) male mice were used for immunostaining to confirm that ErbB4 was knocked out in the CPu and NAc. Western blots using protein lysates from five Con and five cKO mice further confirmed our results. Both staining and Western blotting results were analyzed by unpaired two-tailed t test for statistical difference between the two groups.
We next detected the behavior difference between 16 Con and 16 cKO mice for open-field analysis, 13 Con and 14 cKO mice for three chamber exploration analysis, and 16 Con and 15 cKO mice for PPI analysis using two-way ANOVA with Bonferroni post hoc test. Fifteen Con mice and 18 cKO mice were used for the marble-burying test and 13 Con and 14 cKO mice were used for the three chamber preference test and analyzed with unpaired two-tailed t test.
To figure out the underlying mechanism, expression levels of different postsynaptic protein were measured by Western blotting. Protein samples from five Con and five cKO mice for GABAAR α1, four Con and three cKO mice for GABAAR α2, three Con and three cKO mice for GABAAR β2, four Con and three cKO mice for gephyrin, three Con and three cKO mice for GluN2A, three Con and three cKO mice for GluN2B, and three Con and three cKO mice for GluN1 were used and compared them using unpaired two-tailed t test. To detect ErbB4 and GABAARα1 changes in different brain areas, we used five Con and five cKO mice for the NAc, three Con and three cKO mice for the CPu, three Con and three cKO mice for the prefrontal cortex, three Con and three cKO mice for the hippocampus, and five Con and five cKO mice for the thalamus for Western blotting and compared them using unpaired two-tailed t test. Immunostaining for the GABAARα1 further verified the Western result though the comparison between 43 cells from four Con mice and 51 cells from five cKO mice by unpaired two-tailed t test.
To detect synaptic transmission changes in cKO, we recorded mIPSCs. Fifteen cells from eight Con mice and 14 cells from seven cKO mice in the CPu and 18 cells from five Con mice and 22 cells from five cKO mice in the NAc were used to measure mIPSCs and compared using the Kolmogorov–Smirnov (K-S) t test.
Because GABAAR α1 elevation was detected in the striatum, interfering with its expression may alleviate abnormal behaviors. For the GABAAR α1 RNAi virus validity, three Con mice with scrambled shRNA virus (Con-Scr); three cKO mice with scrambled shRNA virus (cKO-Scr), and three cKO mice receiving GABAAR α1 shRNA (cKO-shRNA) were used for the CPu immunoblots and analyzed by one-way ANOVA with Bonferroni post hoc test. Twenty-four cells from four cKO-Scr mice and 50 cells from four cKO-shRNA mice were used for the NAc immunostaining confirmed GABAAR α1 interference effect after the results were tested by unpaired two-tailed t test.
To detect behavior changes after GABAAR α1 interference in the DMS, 12 Con-Scr mice, 12 cKO-Scr mice, and 10 cKO-shRNA mice were used for open-field analysis; 12 Con-Scr mice, eight cKO-Scr mice, and nine cKO-shRNA mice for three chamber analysis; and 12 Con-Scr mice, eight cKO-Scr mice, and nine cKO-shRNA mice for PPI analysis were analyzed by two-way ANOVA with Bonferroni post hoc test. Twelve Con-Scr mice, eight cKO-Scr mice, and nine cKO-shRNA mice were tested for marble-burying analysis and compared with one-way ANOVA with Bonferroni post hoc test.
To test behavior changes after GABAAR α1 interference in the NAc core, eight Con-Scr mice, 14 cKO-Scr mice, and 12 cKO-shRNA mice for open-field analysis; 11 Con-Scr mice, 12 cKO-Scr mice, and 13 cKO-shRNA mice for three chamber exploration analysis; and 10 Con-Scr mice, 14 cKO-Scr mice, and 14 cKO-shRNA mice for PPI analysis were used and data were analyzed by two-way ANOVA with Bonferroni post hoc test. Behavioral data from 12 Con-Scr mice, 15 cKO-Scr mice, and 14 cKO-shRNA mice for marble-burying analysis and 11 Con-Scr mice, 12 cKO-Scr mice, and 13 cKO-shRNA mice for the three chamber preference analysis were tested by one-way ANOVA with Bonferroni post hoc test.
We further detected changes of mIPSCs after GABAAR α1 interference in the NAc core; 20 cells from five cKO-Scr mice and 22 cells from four cKO-shRNA mice were used for the mIPSC recording and statistical analysis was performed using the K-S t test.
To explore the role of ErbB4 in the NAc core, we injected AAV-fDIO-Cre-EGFP virus to the NAc core in Dlx5/6-flp;Ai65 mice. A total of 428 cells from three AAV-fDIO-EGFP-transfected mice and 844 cells from four AAV-fDIO-Cre-EGFP-transfected mice were tested for the virus validity. By performing unpaired two-tailed t test of fluorescent intensity of 1509 cells from three NAc-Con mice and 1854 cells from three NAc-cKO mice after DARPP32 staining, the viral transfection efficiency and reliability in the Con or cKO animals were verified.
To determine Erbb4 deletion and GABAAR α1 knock-down in the NAc core, 2395 cells from three NAc-Con mice and 2023 cells from four NAc-cKO mice were compared for ErbB4 immunostaining fluorescent intensity. Protein lysates from four NAc-Con mice and four NAc-cKO mice were immunoblotted for ErbB4 and GABAAR α1. Results of both immunostaining and immunoblotting were analyzed by unpaired two-tailed t test. Eight cells from four NAc-Con mice and 50 cells from five NAc-cKO mice were used for GABAAR α1 immunostaining, followed by unpaired two-tailed t test of staining intensity. Twenty-eight cells from four NAc-Con mice and 25 cells from three NAc-cKO mice were compared for mIPSCs by K-S t test.
In testing behavior changes after precise Erbb4 deletion in the NAc core, behavior performance of 16 NAc-Con mice and 16 NAc-cKO mice was used for open-field analysis, 14 NAc-Con mice and 13 NAc-cKO mice for three chamber exploration analysis, and 15 NAc-Con mice and 15 NAc-cKO mice for PPI analysis and tested by two-way ANOVA with Bonferroni post hoc test. Fifteen NAc-Con mice and 15 NAc-cKO mice were used for marble-burying analysis and 14 NAc-Con mice and 13 NAc-cKO mice for three chamber preference analysis were analyzed by unpaired two-tailed t test.
All data areexpressed as mean ± SEM. Normal distribution was assessed by the Shapiro–Wilk statistical test. The null hypothesis, stating that the population is normally distributed, is accepted when α is determined as ≥0.05. For all behavior tests, immunostaining, Western blot, and electrophysiology recording, only male mice were used. The sample size (mice/slices/cells) was approved by power analysis using the G*power 3.1.9.2 and is listed for each experiment in the figure legends. All experiments were from at least three mice and the exact p-values are shown in the results. Statistical analyses were performed in Origin 8.0 software. Significance was determined and is reported as follows: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Results
Behavioral deficits in Erbb4 conditional mutants
Dlx5/6-cre-transgenic mice express Cre recombinase in GABAergic forebrain neurons, including striatal MSNs (Zerucha et al., 2000). To confirm the Cre expression pattern, we crossed Dlx5/6-cre mice with the Ai9-tdTomato reporter line to detect the cre-positive neuron distribution. The direct striatonigral pathway could be detected distinctly in the sagittal section (Fig. 1A) and tdTomato-positive neurons were densely distributed in the forbrain areas such as the somatosensory cortex (Fig. 1B), striatum (Fig. 1C), hippocampus (Fig. 1D), and hypothalamus (Fig. 1E). Furthermore, both dorsal striatum and ventral striatum had a td-Tomato-positive neuron distribution (Fig. 2A). To identify the neuronal subtypes of tdTomato-positive neurons in the striatum subregions the CPu and the NAc, we stained brain sections from Dlx5/6-cre;Ai9 mice for the MSN marker DARPP32, for PV, and for ChAT. tdTomato colocalized well with DARPP32, but not PV or ChAT in the CPu (Fig. 1F) and the NAc (Fig. 2B,C), suggesting that genetic ablation using Dlx5/6-cre results in gene deletion in MSNs, but not in cholinergic neurons in the striatum.
By crossing Dlx5/6-cre with Erbb4loxp/loxp mice (García-Rivello et al., 2005), we generated Dlx5/6-cre;Erbb4loxp/loxp ErbB4 cKO mice and littermate Erbb4loxp/loxp controls. Immunostaining showed that ErbB4 is abundantly expressed in MSNs in the CPu (Fig. 1G) and the NAc (Fig. 2D,E) in the controls, but is absent in MSNs of the CPu (t(6) = 5.367, p ≪ 0.01; Fig. 1G) and the NAc (t(11) = 70.944, p ≪ 0.01; Fig. 2D,E) in the cKO mice. Western blotting of the NAc further confirmed that ErbB4 was knocked down in cKO mice (t(8) = 5.415, p ≪ 0.01; Fig. 2F,G).
To investigate the behaviors mediated by ErbB4 in striatal MSNs, we subjected these mice to a series of behavioral tests. cKO mice traveled for longer distances in 15 min open-field tests, indicating the presence of hyperactivity (F(2,14) = 0.266, p = 0.025 in the second 5 min, p = 0.018 in the third 5 min; Fig. 3A). The travel distance in the center was not different, indicating that hyperactivity was not dependent on anxiety level (data not shown). The elevated plus maze was also used to further evaluate anxiety behavior. We observed similar exploration times in both the open arms and the closed arms for the cKO and control groups (data not shown), suggesting that cKO mice did not exhibit anxiety-like behavior. cKO mice buried fewer marbles compared with controls in the marble-burying test (t(31) = 6.954, p ≪ 0.01; Fig. 3B).
To evaluate social or cognitive behavior changes in cKO mice, we subjected these mice to the three-chamber test and the PPI test. In the three-chamber social ability test, cKO mice displayed a normal social ability to identify their conspecifics (F(1,25) = 1.518, p ≪ 0.01, Fig. 3C; t(25)= −0.828, p = 0.427, Fig. 3D), but failed to recognize a new arrival, indicating impaired social novelty recognition (F(1,25) = 18.8, p ≪ 0.01, Fig. 3E; t(25) = 6.022, p ≪ 0.01, Fig. 3F). We also measured sensorimotor gating function by analyzing the startle reflex in the PPI test. Although both groups responded similarly to the startle stimulus without a prepulse (data not shown), inhibition by prepulse stimulation was significantly lower in cKO mice, demonstrating impaired sensorimotor gating function (F(2,27) = 1.943, p ≪ 0.01; Fig. 3G).
Loss of ErbB4 elevates GABAA receptor α1 expression, particularly in the striatum
Erbb4 deletion in cortical areas compromises local GABAergic synaptic formation and transmission (Fazzari et al., 2010; Del Pino et al., 2013; Yang et al., 2013). To test whether Erbb4 deletion has a similar effect on striatal synaptic connections, we analyzed the expression of GABAergic and glutamatergic components in the striatum of 8- to 13-week-old mice. Surprisingly, GABAAR α1 expression was significantly increased in the striatum in the Erbb4 mutant mice (t(8) = −4.212, p ≪ 0.01; Fig. 4A,B), whereas, in comparison, no significant differences in other GABAA receptor subunits, the α2 (t(5) = 0.134, p = 0.866; Fig. 4A,B) and the β2 (t(4) = −1.524, p = 0.168; Fig. 4A,B) and the inhibitory postsynaptic protein gephyrin (t(5) = −1.021, p = 0.46; Fig. 4C,D) or in the glutamatergic components GluN1 (t(4) = 0.123, p = 0.98; Fig. 4C,D), GluNR2A (t(4) = −0.224, p = 0.86; Fig. 4C,D) and GluNR2B (t(4) = 0.766, p = 0.14; Fig. 4C,D) were detected. Because Dlx5/6-cre mice had other forebrain area GABAergic interneurons labeled, we further wanted to confirm whether GABAAR α1 elevation had region specificity. The ErbB4 protein was did deleted in different forebrain areas such as the NAc (t(8) = 5.415, p ≪ 0.01; Fig. 4E,F), the CPu (t(4) = 4.142, p = 0.014; Fig. 4E,F), the prefrontal cortex (t(4) = 3.623, p = 0.022; Fig. 4E,F), the hippocampus (t(4) = 6.684, p ≪ 0.01; Fig. 4E,F), and the hypothalamus (t(4) = 3.96, p = 0.017; Fig. 4E,F). However, GABAAR α1 increase was just detected in the striatum subregions including the NAc (t(8) = −3.029, p = 0.016; Fig. 4E,G) and the CPu (t(4) = −7.814, p ≪ 0.01; Fig. 4E,G), not in other forebrain regions, including the prefrontal cortex (t(4) = −0.033, p = 0.975; Fig. 4E,G), the hippocampus (t(4) = 0.262, p = 0.807; Fig. 4E,G), and the hypothalamus (t(4) = 0.416, p = 0.699; Fig. 4E,G). Western blotting results were corroborated by immunostaining of brain slices for GABAAR α1 in the striatum, which showed higher fluorescence intensity in the cKO group (t(7) = −10.34, p ≪ 0.01; Fig. 4H,I).
As a critical component of GABA receptors, GABAAR α1 closely participates in GABAergic synaptic transmission (Okada et al., 2000; Vicini et al., 2001). To investigate whether the upregulation of GABAAR α1 altered striatal GABAergic synaptic transmission, we prepared acute brain slices and performed whole-cell recordings in the NAc and the CPu. The identified action potentials and the mIPSC traces of MSNs in the CPu and NAc were shown in Figure 5, A, B, and G. Interestingly, both the amplitude and frequency of the mIPSCs in MSNs in the CPu (t(27) = −2.132, p ≪ 0.01, Fig. 5C,D; t(27) = −2.253, p ≪ 0.01, Fig. 5E,F) and the NAc (t(38) = −2.739, p ≪ 0.0, Fig. 5H,I; t(38) = −5.254, p ≪ 0.01, Fig. 5J,K) of cKO mice were significantly increased compared with the controls. In contrast, the amplitude and frequency of the miniature EPSC (mEPSC) were similar between control and cKO mice (data not shown). These results indicate that the loss of ErbB4 in striatal MSNs specifically enhances GABAergic but not glutamatergic synaptic transmission.
Knock-down of GABAAR α1 in the NAc core but not the dorsomedial striatum restores behavior performance
The NAc core and the DMS have been implicated in cognition and motivation behavior (Cardinal et al., 2001; Yin et al., 2005; Balleine et al., 2007; Mai et al., 2015). Dysfunction of the NAc core leads to impulsive choice, whereas damage to the two afferents, the anterior cingulate cortex and the medial prefrontal cortex, had no effect on this capacity (Cardinal et al., 2001). The DMS is preferentially recruited during skill learning compared with the DLS (Yin et al., 2009). Inspired by these studies, we further examined whether the NAc core and/or the DMS were involved in these abnormal behaviors of ErbB4 mutants.
To test whether elevated GABAAR α1 expression causes these behavior deficits, we bilaterally injected virus expressing GABAAR α1 short hairpin RNA (shRNA) along with GFP (AAV-α1-shRNA-GFP) to specifically knock down GABAAR α1 in the DMS (Fig. 6A) or the NAc core (Fig. 7A) in cKO mice. Animals that received viruses expressing scrambled shRNA with GFP (AAV-scramble-GFP) served as controls (Con-Scr, Con mice with scrambled shRNA virus; cKO-Scr, cKO mice with scrambled shRNA virus). Three weeks after virus injection, we validated the knock-down efficiency in the injected animals and performed a series of behavioral, immunohistochemical, Western blot's and electrophysiological assays. To exclude the possible interference of off-target viral injection on behavioral performance, mice which finished behavioral tests first were perfused, fixed, and checked for GFP fluorescence in the targeted region after brain tissue sections were prepared. Behavioral data from those with GFP fluorescence beyond the targeted regions were excluded from statistical analysis of behavioral results. For immunohistochemical and electrophysiological analysis, brain sections were prepared and viral injection accuracy was confirmed before any following assays. For Western blot experiments, the potential off-target effect was minimized by three factors: 1) only tissues from targeted regions were collected; 2) chances of off-target viral infection were equal among all groups; 3) each group have multiple replicates. Overall, our transfection efficiency and virus reliability exceeded 80% (data not shown). GABAARα1 expression was significantly decreased in the DMS (F(2,6) = 10.82, p = 0.01; Fig. 6B,C) and the NAc core (t(6) = 8.915, p ≪ 0.01; Fig. 7B,C) of AAV-α1-shRNA-GFP-infected mice.
In the cKO-shRNA mice in the DMS, we detected no effect on open-field test (F(2,32) = 0.123, p = 0.974; Fig. 6D), marble-burying test (F(2,26) = 25.38, p = 0.923; Fig. 6E), three chamber test (F(2,27) = 0.104, p = 0.532, Fig. 6F; F(2,27) = 0.82, p = 0.45, Fig. 6G), or PPI test (F(2,27) = 0.673, p = 0.519; Fig. 6H). In contrast to the failure of behavior rescue by GABAAR α1 shRNA in the DMS, GABAAR α1 knock-down in the NAc core of cKO mice showed a marked difference. Hyperactivity (F(2,31) = 5.359, p = 0.014; Fig. 7D), aberrant marble-burying performance (F(2,38) = 59.441, p ≪ 0.01; Fig. 7E), social novelty recognition deficits (F(2,33) = 0.251, p = 0.779, Fig. 7F; F(2,33) = 10.35, p ≪ 0.01, Fig. 7G; F(2,33) = 0.875, p = 0.426, Fig. 7H; F(2,33) = 8.015, p ≪ 0.01, Fig. 7I), and inadequate PPI (F(2,35) = 35.27, p ≪ 0.01; Fig. 7J) were all rescued compared with cKO mice infected with viruses expressing scramble shRNA. These results indicate that the change in the NAc core is the primary cause of those behavioral deficits in ErbB4 mutants.
The synaptic transmission was further detected in the NAc core MSNs after GABAAR α1 expression disturbance and the representative mIPSC traces are presented in Figure 8A. Similar to behavioral rescue, knocking down GABAAR α1 in the NAc core of cKO mice restored the amplitude (t(40) = 4.87, p ≪ 0.01; Fig. 8B,C) and frequency (t(6) = 3.635, p ≪ 0.01; Fig. 8D,E) of mIPSCs to control levels.
Local Erbb4 deletion in the NAc core MSNs caused GABAAR α1 overexpression and behavior deficits
We showed above that GABAAR α1 overexpression in the NAc core is necessary for these behavioral abnormalities of Erbb4-deficient mice in which gene deletion was driven by Dlx5/6-Cre. As shown in Figure 1, Cre recombinase is expressed in other forebrain regions aside from the striatum. GABAAR α1 overexpression in the NAc core could therefore be secondary to alter synaptic input from other Erbb4-deficient regions projecting to the NAc or could be due to local Erbb4 deletion in the NAc core MSNs.
To test whether Erbb4 deletion in the NAc core was sufficient to induce these abnormal behaviors, we combined Flp- and Cre-mediated genetic modification to achieve precise Erbb4 deletion in the MSNs of the NAc core and then evaluated animal behavior. We generated Dlx5/6-flp;Erbb4loxp/loxp mice by crossing Dlx5/6-flp mice (Miyoshi et al., 2010) with Erbb4loxp/loxp mice and then stereotactically injecting virus expressing Flp-dependent Cre recombinase (AAV-fDIO-Cre-GFP) into the NAc core of these mice so that Erbb4 could be specifically deleted in the MSNs of the NAc core (NAc-cKO). Dlx5/6-flp;Erbb4loxp/loxp mice injected with control virus expressing only GFP (AAV-fDIO-GFP) served as controls (NAc-Con).
To confirm whether viral AAV-fDIO-Cre-GFP was Flp dependent and initiated Cre recombinase expression, we injected the virus into the Dlx5/6-flp;Ai65 mice in which tdTomato can be activated only when both Cre and Flp recombinase are expressed in the same neuron (Madisen et al., 2015). We detected that the Dlx5/6-flp;Ai65 mice injected with AAV-fDIO-Cre-GFP showed a 90.11% overlap of GFP and tdTomato, whereas AAV-fDIO-GFP did not induce tdTomato expression, indicating the Flp-dependent expression of Cre recombinase in AAV-fDIO-Cre-GFP transfected cells (Fig. 9A,B) and the virus transfection efficiency was considered to be reliable (t(4) = −0.236, p = 0.825; Fig. 9C,D).
To ensure that the virus injection was limited to the NAc core, we checked GFP fluorescence in the brain slices 3 weeks after virus was injected into the Dlx5/6-flp;Erbb4loxp/loxp mice. As expected, the virus expression in most mice was restricted to the NAc core (Fig. 9E). Mice with off-target virus infusion were excluded in all statistical analysis. In the NAc-cKO mice, both immunostaining (t(5) = 70.944, p ≪ 0.01; Fig. 10A,B) and Western blotting (t(6) = 5.94, p ≪ 0.01; Fig. 10C,D) confirmed that ErbB4 was successfully knocked out in the NAc core MSNs. In addition, the elevated expression of GABAAR α1 (t(6) = −3.667, p = 0.0104, Fig. 10C,D; t(6) = −4.085, p ≪ 0.01, Fig. 10E,F) and the increased amplitude (t(51) = −3.342, p ≪ 0.01; Fig. 10G–I) and frequency (t(51) = −3.285, p ≪ 0.01; Fig. 10G,J,K) of mIPSCs were recapitulated in the NAc-cKO mice. Furthermore, NAc-cKO mice also displayed increased locomotion (F(2,30) = 3.216, p = 0.047; Fig. 11A), reduced marble-burying behavior (t(28) = 19.353, p ≪ 0.01; Fig. 11B), and normal sociability (F(2,25) = 0.0037, p = 0.952, Fig. 11C; t(25) = −0.219, p = 0.828, Fig. 11D), but abnormal social novelty recognition (F(2,25) = 70.79, p ≪ 0.01, Fig. 11E; t(25) = 7.144, p ≪ 0.01, Fig. 11F) and decreased PPI (F(2,27) = 1.022, p = 0.021, PP75; p ≪ 0.01, PP80; p ≪ 0.01, PP85; Fig. 11G). In summary, precisely deleting Erbb4 in the NAc core MSNs recapitulated all phenotypes presented by previous cKO mice.
Discussion
Here, we found that the loss of ErbB4 in the striatum, specifically in the NAc core, led to hyperactivity in the open-field test, impaired marble-burying behavior, damaged social novelty recognition in the social ability test, and dysfunctional startle reflex in the PPI test. All of these abnormal behaviors raised the possibility that the striatal ErbB4 mutants presented schizophrenia-like behaviors similar to what was observed in other schizophrenia-like mice models in previous reports (Belforte et al., 2010; Del Pino et al., 2013; Park et al., 2015). Erbb4 deletion induced upregulated GABAAR α1 expression and hyperactive GABAergic synaptic transmission in the striatum. Remarkably, all abnormal behaviors could be rescued by interfering with GABAAR α1 expression in the NAc core. These results highlight the role of ErbB4 in GABAA receptor function in the NAc core and suggest a new molecular mechanism for striatal MSNs in cognitive and social impairments of neuropsychiatric diseases.
ErbB4 in the NAc, but not other striatal subregions, contributes to schizophrenia-like behaviors
Genome-wide analysis of clinical specimens detected various ErbB4 mutations. For instance, ErbB4 kinase domain is partially deleted in one set of schizophrenic patients (Walsh et al., 2008). Biochemical analysis of brain tissues from schizophrenic patients showed that the ErbB4 transcript and protein are elevated in the prefrontal cortex of schizophrenic patients (Silberberg et al., 2006; Chong et al., 2008; Joshi et al., 2014) and that NRG1-induced phosphorylation of ErbB4 kinase is increased in the cortex of schizophrenia patients (Hahn et al., 2006). PSD-95 can interact with ErbB4 to regulate hippocampal neuregulin signaling (Huang et al., 2000) and ErbB4 deficits in hippocampus can induce glutamatergic hypofunction (Li et al., 2007). Previous studies about ErbB4 were mainly focused on prefrontal cortex and hippocampus, leaving ErbB4 function in other regions largely unknown (Huang et al., 2000; Neddens and Buonanno, 2010; Tan et al., 2011; Li et al., 2011; Del Pino et al., 2013). In this study, we characterize a novel role of ErbB4 in the striatum in regulating animal behavior.
The striatum includes multiple subregions. As for schizophrenia, patients with first-episode schizophrenia display a significant volumetric reduction in the NAc (Bois et al., 2015). In a schizophrenia rat model, aberrant high-frequency oscillations are recorded in the NAc (Goda et al., 2015). These studies highlight an important role for the NAc in mediating schizophrenia pathogenesis. The NAc core, but not the shell, has been reported to modulate risk-based decision making and cocaine-seeking behavior (Ito et al., 2004; Mai et al., 2015) and a lesion in the NAc core can induce persistent impulsive choice (Cardinal et al., 2001). These studies indicate that the core has a greater role in regulating cognitive and motivational behaviors than the shell. Our accumulating evidence suggests that Erbb4 deletion in the NAc core could induce schizophrenia-like behaviors, thus supporting the role of the NAc core in mediating schizophrenia.
The DMS, but not the DLS, is reported to be involved in encoding action–outcome associations in instrumental conditioning (Yin et al., 2005). During the different phases of skill learning, the DMS was preferentially more engaged than the DLS in training (Yin et al., 2009). The DMS plays a more important role in mediating goal-directed behavior, whereas the DLS mainly participates in habit-driven behavior (Burton et al., 2015). Therefore, the DMS may take the prior place in modulating motivational behaviors than the DLS. Decreasing GABAAR α1 expression in the DMS failed to rescue most of the behavioral changes in Erbb4 mutant mice (Fig. 6D–H), although both the NAc and DMS showed α1 overexpression in Erbb4 mutant mice (Fig. 4E). This indicates that the NAc core and DMS may be involved in different aspects of these behaviors. Together, our results indicate that GABAAR α1 plays different roles in the NAc core and DMS and the NAc core may play a more important role in mediating schizophrenia.
Novel cell-type-specific role of ErbB4 in the NAc MSNs in schizophrenia pathophysiology
ErbB4 is mainly expressed in neurons in the brain, including PV-, somatostatin-, and cholecystokinin-expressing neurons (Vullhorst et al., 2009; Del Pino et al., 2013; Bean et al., 2014; Ahrens et al., 2015). Previous studies have described contributing roles of ErbB4 deficiency in PV-expressing neurons to schizophrenia and epilepsy pathogenesis (Tan et al., 2011; Li et al., 2011; Del Pino et al., 2013), in somatostatin-expressing neurons to sensory selection (Ahrens et al., 2015), and in cholecystokinin-expressing neurons to spatial information coding (Del Pino et al., 2017). MSNs, the major GABAergic projection neurons in the NAc, express ErbB4 abundantly and mainly project to areas of the mesencephalon and basal ganglia (Salgado and Kaplitt, 2015). In this study, by manipulating ErbB4 expression in the MSNs, we characterized a novel cell-type-specific function of ErbB4 in regulating animal behavior. Integrating its output pattern with its major inputs from the limbic system, the NAc MSNs has been considered as the functional interface between the limbic and motor systems that plays important roles in reward, addiction, and depression (Krishnan and Nestler, 2008; McEwen et al., 2015; Volkow and Morales, 2015). Projections from VTA to NAc MSNs encode and predict key features of social behaviors (Gunaydin et al., 2014). Previous studies reported that locomotion, reward, and social interaction are abnormal in schizophrenia mouse models (Del Pino et al., 2013; Luo et al., 2014). Inspired by these findings, we suspected that MSNs in the NAc may be involved in these behaviors. Indeed, our results demonstrated that Erbb4 deletion in the NAc core MSNs can elicit schizophrenia-like behaviors including increased locomotion, abnormal marble-burying behavior, impaired social novelty recognition, and damaged sensorimotor gating function.
Relationship between GABAAR α1 and schizophrenia
GABAAR α1 represents nearly 40% of all GABAA receptors and the expression of its gene has been shown to be altered in schizophrenia patients using a two-stage candidate gene association approach (Petryshen et al., 2005; Rudolph and Knoflach, 2011). α1 subunit mRNA levels are decreased in schizophrenia and epilepsy patients (Dean, 2002; Lewis and González-Burgos, 2008; Charych et al., 2009; Rico and Marín, 2011). In mice, it has been reported that ErbB4-null mice have diminished cortical GABAAR α1 expression (Mitchell et al., 2013). However, we found that GABAAR α1 subunit expression was elevated in the striatum in the absence of ErbB4, which suggested there may be a region-specific control of the GABAA receptor expression in schizophrenia. shRNA knock-down of GABAAR α1 in the NAc core of cKO mice confirmed that elevated GABAAR α1 expression in the NAc leads to altered physiology of local MSNs. In the context of normal GABAAR α1 expression in control animals, GABAAR α1 knock-down specifically in MSNs probably also influences neuronal physiology and animal behavior and will be informative about the general functions of this receptor in these neurons. However, investigation of GABAAR α1 physiological function is out of the scope of this study and will need more extensive efforts in future works.
Cortical and hippocampal ErbB4 may mediate schizophrenia by affecting interneuronal DISC1 or Src kinase, which regulates NMDA activity (Hahn et al., 2006; Pitcher et al., 2011; Seshadri et al., 2015). In contrast, our study proposea the NAc core as a crucial nucleus in ErbB4 participation of schizophrenia and demonstrated that GABAAR α1-dependent GABAergic synaptic transmission in striatal MSNs is the underlying mechanism. GABAA receptors have been tested as therapeutic targets for neurodevelopmental disorders such as autism and epilepsy (Braat and Kooy, 2015). We show that reducing GABAAR α1 expression in MSNs in the NAc core could reverse schizophrenia-like behaviors in Erbb4 mutant mice. The rescue effect of GABAAR α1 interference in Erbb4 mutant mice revealed the first molecular evidence for the regulation of schizophrenia by the NAc core.
Presynaptic and postsynaptic involvement
Deleting ErbB4 in striatal MSNs causes a significant increase in mIPSC amplitude and frequency via increased GABAAR α1 membrane expression. Heterozygous α1 subunit deletion has been reported to reduce the amplitude and frequency of mIPSCs in the ventral basal nucleus, likely due to a partial compensatory mechanism that induces increased inhibitory input from the thalamic reticular nucleus (Zhou et al., 2015a). High-activity treated hippocampal neurons display increased mIPSC amplitude and frequency, whereas GABAA receptors accumulate before changes in GAD65 puncta size, indicating that retrograde signaling may mediate this progress (Rannals and Kapur, 2011). Elevated postsynaptic activity is required for the increase in mIPSC amplitude and frequency in cultured hippocampal neurons caused by GAD65, vGAT, and GABAAR α1 overexpression. Downregulating BDNF in postsynaptic neurons prevents mIPSC enhancement, suggesting that retrograde signaling participates in this process (Peng et al., 2010). We found that Erbb4 deletion increased both mIPSC amplitude and frequency, which were rescued by the interference of GABAAR α1 expression, indicating the possible involvement of a compensatory input mechanism or retrograde signaling pathway.
In conclusion, our work demonstratea that ErbB4 signaling in the NAc core is involved in the pathophysiology of schizophrenia and that the GABAAR α1 subunit may serve as a new molecular target in mediating psychiatric disease development in the NAc core.
Footnotes
This work was supported by the Key Project of the National Natural Science Foundation of China (Grant 31430034), the Major Research Plan of the National Natural Science Foundation of China (Grant 91432306), the National Key Research and Development Plan (Grant YFA050100), the Funds for Creative Research Groups of China (Grant 81221003), the Program for Changjiang Scholars and Innovative Research Team in University, Fundamental Research Funds for the Central Universities (X.-M.L.), and the National Natural Science Foundation of China (Grant 81471150 to J.-M.Y.). We thank Dr. Z. Josh Huang (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) and Dr. Miao He (Institutes of Brain Science, Fudan University, Shanghai, China) for kindly providing Dlx5/6-flp mice. We thank Bo Li (Cold Spring Harbor Laboratory) for kindly providing the pAAV-fDIO-Cre-GFP and pAAV-fDIO-GFP plasmids and Cary Lai (Department of Psychological and Brain Sciences, Indiana University) for the ErbB4 antibody.
The authors declare no competing financial interests.
- Correspondence should be addressed to Xiao-Ming Li, Institute of Neuroscience, Research Building, Room A507, 866 Yuhangtang Road, Hangzhou, 310058 China. lixm{at}zju.edu.cn